Literature DB >> 18188585

Role of a hepatectomy for the treatment of large hepatocellular carcinomas measuring 10 cm or larger in diameter.

Kazuaki Shimada1, Yoshihiro Sakamoto, Minoru Esaki, Tomoo Kosuge.   

Abstract

BACKGROUND: A curative hepatectomy is the mainstay of effective treatment for small hepatocellular carcinoma (HCC), but the treatment of large HCC remains challenging.
MATERIALS AND METHODS: The possible prognostic factors were retrospectively analyzed in 85 patients with large HCC (> or = 10.0 cm) who all underwent a hepatectomy for HCC between 1988 and 2004. A survival analysis was made by classifying the tumors into four spreading patterns according to the number of tumors and the presence of macroscopic tumor thrombus.
RESULTS: A positive hepatitis B antigen, the earlier period of hepatectomy, a non-curative hepatectomy, multiple tumors, and portal vein invasion were identified as independent predictors of a poor prognosis. The median survival term and 5-year survival rate of patients with a solitary large HCC without a macroscopic tumor thrombus was 9.8 years and 69.8%, respectively. The tumor spreading patterns according to the number of tumors and the presence of a macroscopic tumor thrombus were statistically associated with a non-curative hepatectomy (p < 0.001). There was a statistical difference among 33 patients with large HCC undergoing a non-curative hepatectomy based on the presence of a macroscopic portal vein invasion (p = 0.0089).
CONCLUSION: A hepatectomy could yield an excellent long-term survival in patients with a solitary large HCC without a macroscopic tumor thrombus. Even if a curative hepatectomy could not be achieved, a hepatectomy might provide better survival in large HCC patients without a macroscopic tumor thrombus compared in those with macroscopic tumor thrombus.

Entities:  

Mesh:

Year:  2008        PMID: 18188585     DOI: 10.1007/s00423-007-0264-4

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  16 in total

1.  Efficacy of hepatic resection for hepatocellular carcinomas larger than 10 cm.

Authors:  Yasuhiko Nagano; Kuniya Tanaka; Shinji Togo; Kenichi Matsuo; Chikara Kunisaki; Mitsutaka Sugita; Daisuke Morioka; Yasuhiko Miura; Toru Kubota; Itaru Endo; Hitoshi Sekido; Hiroshi Shimada
Journal:  World J Surg       Date:  2005-01       Impact factor: 3.352

2.  Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.

Authors:  Kenichi Takayasu; Shigeki Arii; Iwao Ikai; Masao Omata; Kiwamu Okita; Takafumi Ichida; Yutaka Matsuyama; Yasuni Nakanuma; Masamichi Kojiro; Masatoshi Makuuchi; Yoshio Yamaoka
Journal:  Gastroenterology       Date:  2006-08       Impact factor: 22.682

3.  Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection: an analysis of 610 patients over 16 years old.

Authors:  Kojiro Taura; Iwao Ikai; Etsuro Hatano; Hideaki Fujii; Naoki Uyama; Yasuyuki Shimahara
Journal:  Ann Surg       Date:  2006-08       Impact factor: 12.969

4.  Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter.

Authors:  Ronnie Tung-Ping Poon; Sheung Tat Fan; John Wong
Journal:  J Am Coll Surg       Date:  2002-05       Impact factor: 6.113

5.  Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma.

Authors:  C B O'Suilleabhain; R T P Poon; J L Yong; G C Ooi; W K Tso; S T Fan
Journal:  Br J Surg       Date:  2003-03       Impact factor: 6.939

6.  Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastasis: proposal as a standard therapy.

Authors:  I Ikai; Y Yamaoka; Y Yamamoto; N Ozaki; Y Sakai; S Satoh; N Shinkura; M Yamamoto
Journal:  Ann Surg       Date:  1998-03       Impact factor: 12.969

7.  Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan.

Authors:  Y Shiratori; S Shiina; M Imamura; N Kato; F Kanai; T Okudaira; T Teratani; G Tohgo; N Toda; M Ohashi
Journal:  Hepatology       Date:  1995-10       Impact factor: 17.425

8.  Clinicopathologic features of patients with hepatocellular carcinoma surviving >10 years after hepatic resection.

Authors:  K Shirabe; M Shimada; K Kajiyama; T Gion; Y Ikeda; H Hasegawa; K Taguchi; K Takenaka; K Sugimachi
Journal:  Cancer       Date:  1998-12-01       Impact factor: 6.860

Review 9.  Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization.

Authors:  O Matsui; M Kadoya; J Yoshikawa; T Gabata; K Arai; H Demachi; S Miyayama; T Takashima; M Unoura; K Kogayashi
Journal:  Radiology       Date:  1993-07       Impact factor: 11.105

Review 10.  Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future.

Authors:  W Y Lau; Thomas W T Leung; Simon C H Yu; Stephen K W Ho
Journal:  Ann Surg       Date:  2003-02       Impact factor: 12.969

View more
  13 in total

1.  Hepatocellular carcinoma: clinical study of long-term survival and choice of treatment modalities.

Authors:  Ke-Tong Wu; Cun-Chuan Wang; Li-Gong Lu; Wei-Dong Zhang; Fu-Jun Zhang; Feng Shi; Chuan-Xing Li
Journal:  World J Gastroenterol       Date:  2013-06-21       Impact factor: 5.742

2.  Above 5 cm, size does not matter anymore in patients with hepatocellular carcinoma.

Authors:  Chetana Lim; Yoshihiro Mise; Yoshihiro Sakamoto; Satoshi Yamamoto; Junichi Shindoh; Takeaki Ishizawa; Taku Aoki; Kiyoshi Hasegawa; Yasuhiko Sugawara; Masatoshi Makuuchi; Norihiro Kokudo
Journal:  World J Surg       Date:  2014-11       Impact factor: 3.352

3.  Transcatheter arterial chemoembolization followed by immediate radiofrequency ablation for large solitary hepatocellular carcinomas.

Authors:  Zhi-Jun Wang; Mao-Qiang Wang; Feng Duan; Peng Song; Feng-Yong Liu; Zhong-Fei Chang; Yan Wang; Jie-Yu Yan; Kai Li
Journal:  World J Gastroenterol       Date:  2013-07-14       Impact factor: 5.742

4.  Efficacy of hepatic resection for huge (≥ 10 cm) hepatocellular carcinoma: good prognosis associated with the uninodular subtype.

Authors:  Shao-Liang Zhu; Jie Chen; Hang Li; Le-Qun Li; Jian-Hong Zhong
Journal:  Int J Clin Exp Med       Date:  2015-11-15

5.  Long-term outcome after liver resection for hepatocellular carcinoma larger than 10 cm.

Authors:  Pierre Allemann; Nicolas Demartines; Hanifah Bouzourene; Adrien Tempia; Nermin Halkic
Journal:  World J Surg       Date:  2013-02       Impact factor: 3.352

6.  Surgery for Intermediate and Advanced Hepatocellular Carcinoma: A Consensus Report from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014).

Authors:  Ming-Chih Ho; Kiyoshi Hasegawa; Xiao-Ping Chen; Hiroaki Nagano; Young-Joo Lee; Gar-Yang Chau; Jian Zhou; Chih-Chi Wang; Young Rok Choi; Ronnie Tung-Ping Poon; Norihiro Kokudo
Journal:  Liver Cancer       Date:  2016-09-14       Impact factor: 11.740

Review 7.  Safety and efficacy of partial hepatectomy for huge (≥10 cm) hepatocellular carcinoma: a systematic review.

Authors:  Yan-Ming Zhou; Bin Li; Dong-Hui Xu; Jia-Mei Yang
Journal:  Med Sci Monit       Date:  2011-02-25

8.  Implementation of a fast-track clinical pathway decreases postoperative length of stay and hospital charges for liver resection.

Authors:  De-Xin Lin; Xuan Li; Qi-Wen Ye; Fen Lin; Lin-Li Li; Qi-Yu Zhang
Journal:  Cell Biochem Biophys       Date:  2011-11       Impact factor: 2.194

9.  Outcome of Hepatectomy for Huge Hepatocellular Carcinoma.

Authors:  Sungho Jo
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2011-05-31

Review 10.  Hepatic resection as a safe and effective treatment for hepatocellular carcinoma involving a single large tumor, multiple tumors, or macrovascular invasion.

Authors:  Jian-Hong Zhong; A Chapin Rodríguez; Yang Ke; Yan-Yan Wang; Lin Wang; Le-Qun Li
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.